Equities

Ribomic Inc

4591:TYO

Ribomic Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)84.00
  • Today's Change2.00 / 2.44%
  • Shares traded927.70k
  • 1 Year change-39.57%
  • Beta1.1863
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income(1023)(1652)(1684)
Depreciation/depletion110.4816
Non-Cash items46(3.2)35
Cash taxes paid, supplemental1.081.311.27
Cash interest paid, supplemental------
Changes in working capital34(54)134
Total cash from operations(933)(1709)(1499)
INVESTING
Capital expenditures(23)(24)(10)
Other investing and cash flow items, total200300700
Total cash from investing177276690
FINANCING
Financing cash flow items0.531.32--
Total cash dividends paid------
Issuance (retirement) of stock, net271,332355
Issuance (retirement) of debt, net------
Total cash from financing281,334355
NET CHANGE IN CASH
Foreign exchange effects2.402219
Net change in cash(725)(77)(436)
Net cash-begin balance/reserved for future use2,8252,9023,338
Net cash-end balance/reserved for future use2,1002,8252,902
SUPPLEMENTAL INCOME
Depreciation, supplemental110.4816
Cash interest paid, supplemental------
Cash taxes paid, supplemental1.081.311.27
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.